Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
暂无分享,去创建一个
Cyril Dalmasso | Laurence Meyer | Sigrid Le Clerc | Faroudy Boufassa | P. Debré | C. Rouzioux | L. Meyer | O. Lambotte | W. Carpentier | C. Goujard | J. Delfraissy | F. Boufassa | Cécile Goujard | Jean-François Delfraissy | M. Chaix | C. Dalmasso | V. Avettand-Fenoel | S. Le Clerc | Laure Denis de Senneville | C. Deveau | P. Broet | I. Theodorou | Christine Rouzioux | Marie-Laure Chaix | Olivier Lambotte | Patrice Debré | Ioannis Theodorou | Wassila Carpentier | Christiane Deveau | Véronique Avettand-Fenoel | Philippe Broet
[1] K. Jeang,et al. Role of RNA helicases in HIV-1 replication , 2006, Nucleic acids research.
[2] C. Rouzioux,et al. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection , 2000, AIDS.
[3] J. Reveille,et al. Molecular basis of complete C4 deficiency in a SLE patient with four mutant genes: A 2- BP insertion at exon 29 in C4A and A 1-BP deletion at exon 13 in C4B , 2000 .
[4] J. Esko,et al. Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion , 2004, Journal of Virology.
[5] D. Boos. On Generalized Score Tests , 1992 .
[6] J. Wojcik,et al. A Fast, Unbiased and Exact Allelic Test for Case-Control Association Studies , 2006, Human Heredity.
[7] H. Ullum,et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. , 2001, Annals of internal medicine.
[8] J. Lieberman,et al. Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.
[9] S. Riddell,et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. , 2001, Nature immunology.
[10] D. Clayton,et al. An R Package for Analysis of Whole-Genome Association Studies , 2007, Human Heredity.
[11] J. Goedert,et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.
[12] F. Ramos-Morales,et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG , 1998, Oncogene.
[13] J. Reveille,et al. The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes1 , 2002, The Journal of Immunology.
[14] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[15] E. Bruford,et al. Mammalian SP/KLF transcription factors: bring in the family. , 2005, Genomics.
[16] Scott F. Saccone,et al. A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci , 2008, PLoS genetics.
[17] Yi Xie,et al. Identification of a novel human DDX40 gene, a new member of the DEAH-box protein family , 2002, Journal of Human Genetics.
[18] J. Goedert,et al. Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load , 2002, Journal of Virology.
[19] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[20] P. Gallay,et al. Syndecan captures, protects, and transmits HIV to T lymphocytes. , 2003, Immunity.
[21] M. Crossley,et al. Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors. , 1999, The international journal of biochemistry & cell biology.
[22] J. Church. Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2008, Pediatrics.
[23] C. Rouzioux,et al. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy , 2001, AIDS.
[24] L. Zon,et al. The gene encoding TBC1D1 with homology to the tre-2/USP6 oncogene, BUB2, and cdc16 maps to mouse chromosome 5 and human chromosome 4 , 2000, Cytogenetic and Genome Research.
[25] P. Morlat,et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] S. Melmed,et al. An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. , 1999, The Journal of clinical endocrinology and metabolism.
[27] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[28] Tao Dong,et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.
[29] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[30] Eric E. Schadt,et al. Calibrating the Performance of SNP Arrays for Whole-Genome Association Studies , 2008, PLoS genetics.
[31] C. Rouzioux,et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.
[32] L. Laloux,et al. Allelic repertoire of the humanMHC class IMICA gene , 2007, Immunogenetics.
[33] H. Ullum,et al. Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.
[34] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[35] B. Autran,et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.
[36] Amalio Telenti,et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.
[37] F. Hecht,et al. The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection , 2007, Journal of acquired immune deficiency syndromes.
[38] Thierry Moreau,et al. A simple procedure for estimating the false discovery rate , 2005, Bioinform..
[39] C. Rouzioux,et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level , 2003, AIDS.
[40] Todd M. Allen,et al. Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid , 2008, Journal of Virology.
[41] R. Lempicki,et al. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[43] J. Wehland,et al. IrpA , is highly homologous to monocytogenesPrfA-regulated gene in Listeria Identification and characterization of a novel , 1996 .
[44] Laurence Meyer,et al. Does transient HAART during primary HIV-1 infection lower the virological set-point? , 2004, AIDS.
[45] S. Minoshima,et al. Identification and characterization of a novel gene family YPEL in a wide spectrum of eukaryotic species. , 2004, Gene.
[46] L. Laloux,et al. Allelic repertoire of the human MHC class I MICA gene. , 1996, Immunogenetics.
[47] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[48] J. Schalkwijk,et al. Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.
[49] J. Mellors,et al. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. , 1991, The Journal of infectious diseases.
[50] Asier Sáez-Cirión,et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.
[51] L. Laloux,et al. Allelic repertoire of the human MICB gene , 1997, Immunogenetics.
[52] Pardis C Sabeti,et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.
[53] C. Rouzioux,et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] Radu V. Craiu,et al. Stratified false discovery control for large‐scale hypothesis testing with application to genome‐wide association studies , 2006, Genetic epidemiology.